Soy-Derived Isoflavones Linked to Reduced Respiratory Morbidity and Mucus Clearing in Former Smokers

New research from April 2026 shows isoflavones in soy can reduce COPD cough and mucus symptoms by lowering platelet activation in former smokers.

By: AXL Media

Published: Apr 28, 2026, 10:26 AM EDT

Source: Information for this report was sourced from News-Medical.net

Dietary Interventions in Chronic Airflow Obstruction

The management of Chronic Obstructive Pulmonary Disease (COPD) has traditionally focused on pharmacological bronchodilation, but emerging research is shifting the spotlight toward modifiable nutritional factors. A study recently released in the journal Chronic Obstructive Pulmonary Diseases has identified a significant association between the consumption of isoflavones, phenolic compounds prevalent in legumes and soy, and improved health status in former smokers. Unlike Western dietary patterns that often exacerbate systemic inflammation, the inclusion of soy based nutrients appears to mitigate the persistent symptoms of cough and sputum production that characterize the disease's morbidity.

Investigating the Urban CURE COPD Cohort

The research was conducted within the urban arm of the CURE COPD study, focusing on low income patients in Baltimore, Maryland, who had a substantial smoking history averaging over 46 pack years. Lead author Daniel C. Belz, M.D., and his team tracked 99 participants with moderate to severe airflow limitation over a six month period, utilizing both clinical visits and monthly interviews. By cross referencing Food Frequency Questionnaires with validated respiratory assessments like the COPD Assessment Test (CAT), the researchers sought to isolate the specific impact of isoflavone intake on a demographic frequently exposed to poor air quality and high neighborhood poverty.

Measurable Improvements in Respiratory Symptoms

Statistical analysis revealed that for every standard deviation increase in total isoflavone intake, participants experienced a two point reduction in their CAT scores, a result that meets the threshold for minimal clinically important difference. Improvements were also noted in the Clinical COPD Questionnaire and the Ease of Cough and Sputum Clearance (ECSC) scores. While the study did not find a significant link between soy consumption and a reduction in total exacerbation rates or lung function (FEV1), the consistent lowering of symptom scores suggests that dietary isoflavones play a functional role in enhancing the daily quality of life for symptomatic patients.